Tempest Therapeutics, Inc. (Nasdaq: TPST), a clinical-stage biotechnology company developing first-in-class i targeted and immune-mediated therapeutics to fight cancer, today announced that an ...

It’s another standard of excellence in cinema—and we’d argue that there’s indeed correlation between great posters and great films. Consider: In our (admittedly wildly unscientific!) ...